mRNA-Seq of Single Prostate Cancer Circulating Tumor Cells Reveals Recapitulation of Gene Expression and Pathways Found in Prostate Cancer

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Cann, Gordon M ^a   Gulzar, Zulfiqar G ^b   Cooper, Samantha ^a   Li, Robin ^a   Luo, Shujun ^a   Tat, Mai ^a   Stuart, Sarah ^a   Schroth, Gary ^a   Srinivas, Sandhya ^c   Ronaghi, Mostafa ^a   Brooks, James D ^b   Talasaz, AmirAli H ^a  

^a ILLUMINA INC   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; CD4 ANTIGEN; FLUORESCENT DYE; MESSENGER RNA; PROSTATE SPECIFIC ANTIGEN;

APOPTOSIS; AR GENE; ARTICLE; CANCER CELL CULTURE; CELL COUNT; CELL ISOLATION; CIRCULATING TUMOR CELL; COMPUTER PROGRAM; FLUORESCENCE ANALYSIS; GENE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; KLK3 GENE; LEUKOCYTE; METASTASIS POTENTIAL; PROSTATE CANCER; QUALITY CONTROL; RNA SEQUENCE; SEQUENCE ANALYSIS; TMPRSS2 GENE;

CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; METABOLIC NETWORKS AND PATHWAYS; NEOPLASM METASTASIS; NEOPLASTIC CELLS, CIRCULATING; PROGNOSIS; PROSTATIC NEOPLASMS; RNA, MESSENGER; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, RNA; TUMOR MARKERS, BIOLOGICAL;

EID: 84868709258     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049144     Document Type: Article

References (46)

1. Chaffer CL, Weinberg RA, (2011) A perspective on cancer cell metastasis. Science 331: 1559-1564.
2. Valastyan S, Weinberg RA, (2011) Tumor metastasis: molecular insights and evolving paradigms. Cell 147: 275-292.
3. Hanahan D, Weinberg RA, (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674.
4. Ashworth TR, (1869) A case of cancer in which cells similar to those in the tumors were seen in the blood after death. Aust Med J 14: 146-149.
5. Cristofanilli M, Hayes DF, Budd GT, Ellis MJ, Stopeck A, et al. (2005) Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. J Clin Oncol 23: 1420-1430.
6. Cohen SJ, Punt CJ, Iannotti N, Saidman BH, Sabbath KD, et al. (2008) Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol 26: 3213-3221.
7. Danila DC, Heller G, Gignac GA, Gonzalez-Espinoza R, Anand A, et al. (2007) Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer. Clin Cancer Res 13: 7053-7058.
8. Stott SL, Lee RJ, Nagrath S, Yu M, Miyamoto DT, et al. (2010) Isolation and characterization of circulating tumor cells from patients with localized and metastatic prostate cancer. Sci Transl Med 2: 25ra23.
9. Danila DC, Pantel K, Fleisher M, Scher HI, (2011) Circulating tumors cells as biomarkers: progress toward biomarker qualification. Cancer J 17: 438-450.
10. Lianidou ES, Markou A, (2011) Circulating tumor cells as emerging tumor biomarkers in breast cancer. Clin Chem Lab Med 49: 1579-1590.
11. Vona G, Sabile A, Louha M, Sitruk V, Romana S, et al. (2000) Isolation by size of epithelial tumor cells: a new method for the immunomorphological and molecular characterization of circulatingtumor cells. Am J Pathol 156: 57-63.
12. Nagrath S, Sequist LV, Maheswaran S, Bell DW, Irimia D, et al. (2007) Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 450: 1235-1239.
13. Stott SL, Hsu CH, Tsukrov DI, Yu M, Miyamoto DT, et al. (2010) Isolation of circulating tumor cells using a microvortex-generating herringbone-chip. Proc Natl Acad Sci U S A 107: 18392-18397.
14. Ghossein RA, Scher HI, Gerald WL, Kelly WK, Curley T, et al. (1995) Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma: clinical implications. J Clin Oncol 13: 1195-1200.
15. Racila E, Euhus D, Weiss AJ, Rao C, McConnell J, et al. (1998) Detection and characterization of carcinoma cells in the blood. Proc Natl Acad Sci U S A 95: 4589-4594.
16. Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, et al. (2004) Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 351: 781-791.
17. Paris PL, Kobayashi Y, Zhao Q, Zeng W, Sridharan S, et al. (2009) Functional phenotyping and genotyping of circulating tumor cells from patients with castration resistant prostate cancer. Cancer Lett 277: 164-173.
18. Alix-Panabieres C, Vendrell JP, Slijper M, Pelle O, Barbotte E, et al. (2009) Full-length cytokeratin-19 is released by human tumor cells: a potential role in metastatic progression of breast cancer. Breast Cancer Res 11: R39.
19. Marrinucci D, Bethel K, Bruce RH, Curry DN, Hsieh B, et al. (2007) Case study of the morphologic variation of circulating tumor cells. Hum Pathol 38: 514-519.
20. Ntouroupi TG, Ashraf SQ, McGregor SB, Turney BW, Seppo A, et al. (2008) Detection of circulating tumour cells in peripheral blood with an automated scanning fluorescence microscope. Br J Cancer 99: 789-795.
21. Magbanua MJ, Sosa EV, Scott JH, Simko J, Collins C, et al. (2012) Isolation and genomic analysis of circulating tumor cells from castration resistant metastatic prostate cancer. BMC Cancer 12: 78.
22. Talasaz AH, Powell AA, Huber DE, Berbee JG, Roh KH, et al. (2009) Isolating highly enriched populations of circulating epithelial cells and other rare cells from blood using a magnetic sweeper device. Proc Natl Acad Sci U S A 106: 3970-3975.
23. Powell AA, Talasaz AH, Zhang H, Coram MA, Reddy A, et al. (2012) Single cell profiling of circulating tumor cells: transcriptional heterogeneity and diversity from breast cancer cell lines. PLoS One 7: e33788.
24. Leary RJ, Kinde I, Diehl F, Schmidt K, Clouser C, et al. (2010) Development of personalized tumor biomarkers using massively parallel sequencing. Sci Transl Med 2: 20ra14.
25. Navin N, Kendall J, Troge J, Andrews P, Rodgers L, et al. (2011) Tumour evolution inferred by single-cell sequencing. Nature 472: 90-94.
26. Eisen MB, Spellman PT, Brown PO, Botstein D, (1998) Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 95: 14863-14868.
27. Robinson MD, McCarthy DJ, Smyth GK, (2010) edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26: 139-140.
28. Thomas PD, Kejariwal A, Campbell MJ, Mi H, Diemer K, et al. (2003) PANTHER: a browsable database of gene products organized by biological function, using curated protein family and subfamily classification. Nucleic Acids Res 31: 334-341.
29. van Bokhoven A, Varella-Garcia M, Korch C, Johannes WU, Smith EE, et al. (2003) Molecular characterization of human prostate carcinoma cell lines. Prostate 57: 205-225.
30. Ateeq B, Tomlins SA, Laxman B, Asangani IA, Cao Q, et al. (2011) Therapeutic targeting of SPINK1-positive prostate cancer. Sci Transl Med 3: 72ra17.
31. Gulzar ZG, McKenney JK, Brooks JD, (2012) Increased expression of NuSAP in recurrent prostate cancer is mediated by E2F1. Oncogene.
32. Punnoose EA, Atwal SK, Spoerke JM, Savage H, Pandita A, et al. (2010) Molecular biomarker analyses using circulating tumor cells. PLoS One 5: e12517.
33. Mehes G, Witt A, Kubista E, Ambros PF, (2001) Circulating breast cancer cells are frequently apoptotic. Am J Pathol 159: 17-20.
34. Larson CJ, Moreno JG, Pienta KJ, Gross S, Repollet M, et al. (2004) Apoptosis of circulating tumor cells in prostate cancer patients. Cytometry A 62: 46-53.
35. Del Prete MJ, Robles MS, Guao A, Martinez AC, Izquierdo M, et al. (2002) Degradation of cellular mRNA is a general early apoptosis-induced event. FASEB J 16: 2003-2005.
36. Attard G, Swennenhuis JF, Olmos D, Reid AH, Vickers E, et al. (2009) Characterization of ERG, AR and PTEN gene status in circulating tumor cells from patients with castration-resistant prostate cancer. Cancer Res 69: 2912-2918.
37. Swennenhuis JF, Tibbe AG, Levink R, Sipkema RC, Terstappen LW, (2009) Characterization of circulating tumor cells by fluorescence in situ hybridization. Cytometry A 75: 520-527.
38. Rossi E, Basso U, Celadin R, Zilio F, Pucciarelli S, et al. (2010) M30 neoepitope expression in epithelial cancer: quantification of apoptosis in circulating tumor cells by CellSearch analysis. Clin Cancer Res 16: 5233-5243.
39. Weichert W, Schmidt M, Gekeler V, Denkert C, Stephan C, et al. (2004) Polo-like kinase 1 is overexpressed in prostate cancer and linked to higher tumor grades. Prostate 60: 240-245.
40. Malhotra S, Lapointe J, Salari K, Higgins JP, Ferrari M, et al. (2011) A tri-marker proliferation index predicts biochemical recurrence after surgery for prostate cancer. PLoS One 6: e20293.
41. Hudolin T, Juretic A, Spagnoli GC, Pasini J, Bandic D, et al. (2006) Immunohistochemical expression of tumor antigens MAGE-A1, MAGE-A3/4, and NY-ESO-1 in cancerous and benign prostatic tissue. Prostate 66: 13-18.
42. von Boehmer L, Keller L, Mortezavi A, Provenzano M, Sais G, et al. (2011) MAGE-C2/CT10 protein expression is an independent predictor of recurrence in prostate cancer. PLoS One 6: e21366.
43. Colnaghi R, Connell CM, Barrett RM, Wheatley SP, (2006) Separating the anti-apoptotic and mitotic roles of survivin. J Biol Chem 281: 33450-33456.
44. Zhang M, Latham DE, Delaney MA, Chakravarti A, (2005) Survivin mediates resistance to antiandrogen therapy in prostate cancer. Oncogene 24: 2474-2482.
45. Maheswaran S, Sequist LV, Nagrath S, Ulkus L, Brannigan B, et al. (2008) Detection of mutations in EGFR in circulating lung-cancer cells. N Engl J Med 359: 366-377.
46. Smirnov DA, Zweitzig DR, Foulk BW, Miller MC, Doyle GV, et al. (2005) Global gene expression profiling of circulating tumor cells. Cancer Res 65: 4993-4997.